进口国规制下医药产品出口安全监管演化仿真

doi:10.16182/j.issn1004731x.joss.20-0408

系统仿真学报 ›› 2021, Vol. 33 ›› Issue (9): 2252-2260.doi: 10.16182/j.issn1004731x.joss.20-0408

进口国规制下医药产品出口安全监管演化仿真

李小莉¹, 曹策俊^2,*, 张帆顺³

1.仲恺农业工程学院管理学院,广东广州 510225;
2.重庆工商大学管理科学与工程学院,重庆 400067;
3.暨南大学管理学院,广东广州 510632

收稿日期:2020-06-25 修回日期:2020-08-03 出版日期:2021-09-18 发布日期:2021-09-17
通讯作者: 曹策俊(1990-),男,博士,副教授,硕士生导师,研究方向为灾害运作管理等。E-mail：caocejun0601@tju.edu.cn
作者简介:李小莉(1988-)，女，博士，讲师，研究方向为应急管理等。E-mail：lixiaoli@zhku.edu.cn
基金资助:
国家自然科学基金(71904021); 广东省教育厅青年人才创新项目(KA190578813); 重庆市社会科学规划项目(2019QNGL27); 重庆自然科学基金(cstc2020jcyj-msxmX0164); 教育部‘春晖计划'合作科研项目(CQ2019001); 重庆工商大学“应对重大突发公共卫生事件”专题研究重点项目(ctbuyqzx01); 重庆市教委科学技术研究项目(KJQN201900830); 重庆工商大学校内科研项目(1951025); 重庆工商大学引进高层次人才科研启动项目(1955011)

Evolutionary Simulation of Medical Products Export Safety Supervision Considering Regulation of Importing Country

Li Xiaoli¹, Cao Cejun^2,*, Zhang Fanshun³

1. School of Management, Zhongkai University of Agriculture and Engineering, Guangzhou 510225, China;
2. School of Management Science and Engineering, Chongqing Technology and Business University, Chongqing 400067, China;
3. School of Management, Jinan University, Guangzhou 510632, China

Received:2020-06-25 Revised:2020-08-03 Online:2021-09-18 Published:2021-09-17

摘要/Abstract

摘要： 为研究疫情背景下进口国规制对医药产品出口安全监管的影响,构建了考虑进口国规制的医药产品出口企业与政府监管部门的演化博弈模型,并利用MATLAB仿真,分析了进口国规制程度、惩罚机制等因素对医药产品出口安全监管过程的影响。研究表明,当进口国规制程度高于某一阈值时,可有效约束医药产品出口企业的违规行为,但也会助长政府部门消极监管的行为;从长远来看,单纯加大对医药产品出口企业或政府监管部门的惩罚力度,并不能有效遏制企业的违规行为。

关键词: 新冠病毒, 医药产品, 出口安全, 进口国规制, 政府监管, 演化博弈

Abstract: In order to investigate the impacts of the regulation of importing country on export safety supervision regarding medical products in the COVID-19 epidemic situation, an evolutionary game model considering the relation between export enterprise and supervision of government is constructed. Based on MATLAB simulation, the influences of different factors including regulation level of importing country, punishment mechanism on export safety supervision of medical products are analyzed. Results show that the illegal behaviors of the export enterprises of medical products can be restrained when the regulation level of importing country reaches a certain threshold. But that would fuel the passively supervision behaviors of government. From a long-term perspective, the illegal behaviors of enterprises cannot be effectively controlled by only increasing the level of the penalties on medical exporter or government regulator.

Key words: COVID-19, medical products, export safety, regulation of importing country, government regulation, evolutionary game

中图分类号:

X922
TP391

李小莉, 曹策俊, 张帆顺. 进口国规制下医药产品出口安全监管演化仿真[J]. 系统仿真学报, 2021, 33(9): 2252-2260.

Li Xiaoli, Cao Cejun, Zhang Fanshun. Evolutionary Simulation of Medical Products Export Safety Supervision Considering Regulation of Importing Country[J]. Journal of System Simulation, 2021, 33(9): 2252-2260.

参考文献

[1] 中国日报网. 全球新冠肺炎确诊病例超1000万例[EB/OL].[2020-06-30]. https://edu.163.com/20/0630/ 10/FGC4EC6500297VGM.html.
China Daily Website.There Are More Than 10 million Confirmed Cases of COVID-19 Globally[EB/OL]. [2020-06-30].https://edu.163.com/20/0630/10/FGC4EC6 500297VGM.html.
[2] 新浪网. 多国“点赞”中国医药产品供应:可靠、及时[EB/OL]. (2020-04-28) [2020-05-08]. https://news.sina. com.cn/o/2020-04-28/doc-iircuyvi0312870.shtml.
Sina. Many Countries "Thumb up" Chinese Medical Products Supply: Reliable, Timely[EB/OL]. (2020-04-28) [2020-05-08]. https://news.sina.com.cn/o/2020-04-28/doc- iircuyvi0312870.shtml.
[3] 搜狐网. 海关严打严查！超8千万只口罩被查,20家出口企业被列入“黑名单”[EB/OL]. (2020-04-27) [2020- 05-08]. https://www.sohu.com/a/391599949_151241.
Sohu. Customs Strike Hard! More Than 80 million Masks Have Been Inspected,20 Export Companies Have Been Blacklisted.” [EB/OL]. (2020-04-27) [2020-05-08]. https://www.sohu.com/a/391599949_151241.
[4] 法制日报. 各国进口标准趋严,防疫物资出口要规避这些法律风险[EB/OL]. (2020-04-10) [2020-05-08]. https://www.henandaily.cn/content/2020/0410/224534.html.
Legal Daily. The Import Standards of Various Countries Have Become Stricter,the Export of Epidemic Prevention Materials Should Avoid These Legal Risks[EB/OL]. (2020-04-10) [2020-05-08]. https://www. henandaily.cn/content/2020/0410/224534.html.
[5] 人民日报. 多部门发文:严把产品质量有序开展医疗物资出口[EB/OL]. (2020-04-06) [2020-05-08]. http:// finance.sina.com.cn/china/2020-04-06/doc-iimxxsth3823352.shtml.
People's Daily. Multiple Departments Issued: Stringent Quality Checks, Orderly Export of Medical Supplies [EB/OL]. (2020-04-06) [2020-05-08]. http://finance.sina. com.cn/china/2020-04-06/ doc-iimxxsth3823352.shtml.
[6] Abbott R.Big Data and Pharmacovigilance: Using Health Information Exchanges to Revolutionize Drug Safety[J]. Iowa Law Review (S0021-0552), 2013, 99(1): 225-292.
[7] Rawson, Nigel S B. Drug Safety: Withdrawn Medications Are Only Part of the Picture[J]. BMC Medicine (S1741-7015), 2016, 14(1): 1-3.
[8] Karthik S, John F, Allen K.Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety[J]. Journal of General Internal Medicine (S1365-2796), 2018, 33(11): 2005-2007.
[9] Wengle S.When Experimentalist Governance Meets Science-based Regulations; the Case of Food Safety Regulations[J]. Regulation & Governance (S1748-5991), 2015, 10(3): 262-283.
[10] Ahmad A, Patel I, Sanyal S, et al.A Study on Drug Safety Monitoring Program in India[J]. Indian Journal of Pharmaceutical Sciences (S0250-474X), 2014, 76(5): 379-386.
[11] 方俊. 药品安全协同治理的多主体责任落实——基于我国十大典型药害事件的案例分析[J]. 理论探索, 2020 (1): 92-97.
Fang Jun.Implementation of Multi-agent Responsibility for Coordinated Drug Safety Governance-Based on Case Analysis of Ten Typical Drug Injury Incidents in China[J]. Theoretical Exploration, 2020 (1): 92-97.
[12] 郑小平, 蒋美英, 王晓翠. 基于非结构模糊决策的中国药品安全管理体系研究[J]. 中国安全科学学报, 2008, 18(11): 65-71.
Zheng Xiaoping, Jiang Meiying, Wang Xiaocui.Exploring on China Drug Safety Management System Based on Non-structural Fuzzy Decision[J]. China Safety Science Journal, 2008, 18(11): 65-71.
[13] 张雪, 张维维, 谢明. 基于博弈论分析中药饮片质量监管策略[J]. 中国药房, 2017, 28(7): 872-877.
Zhang Xue, Zhang Weiwei, Xie Ming.The Quality Control Strategy of Chinese Herbal Pieces Based on Game Theory[J]. China Pharmacy, 2017, 28(7): 872-877.
[14] 荣俊美, 朱立龙. 政府管制下双渠道药品供应链质量控制策略[J]. 系统工程, 2019, 37(5): 99-108.
Rong Junmei, Zhu Lilong.The Quality Control Strategy of Dual-channel Drug Supply Chain Under Government Regulation[J]. Systems Engineering, 2019, 37(5): 99-108.
[15] 朱立龙, 荣俊美. 药品供应链质量投入与政府分层监管策略研究[J]. 软科学, 2019, 33(2): 26-31.
Zhu Lilong, Rong Junmei.Quality Investment and Government Stratification Supervision Strategy in Drug Supply Chain[J]. Soft Science, 2019, 33(2): 26-31.
[16] 宋燕, 甄天民. 药品安全监管的演化博弈与对策分析[J]. 中国药房, 2016, 27(19): 2593-2595.
Song Yan, Zhen Tianmin.Analysis on Evolutionary Game and Countermeasures for Drug Safety Regulation[J]. China Pharmacy, 2016, 27(19): 2593-2595.
[17] 吴元元. 信息基础、声誉机制与执法优化——食品安全治理的新视野[J]. 中国社会科学, 2012(6): 115-133.
Wu Yuanyuan. Information Infrastructure, Reputation Mechanism and the Optimization of Law Enforcement: A New View of Food Safety Management[J]. Social Sciences in China, 2012(6): 115-133.
[18] 李小莉. 考虑声誉的公私合作项目监管演化博弈分析[J]. 系统工程学报, 2017, 32(2): 199-206.
Li Xiaoli.Evolution Game Analysis of PPP Projects Regulatory With Consideration of Reputation[J]. Journal of Systems Engineering, 2017, 32(2): 199-206.
[19] 新浪网. 新增2例境外输入病例, 此外还有一个好消息！[EB/OL]. (2020-05-07) [2020-05-08]. https://news. sina.com.cn/c/2020-05-07/ doc-iirczymk0253210.shtml.
Sina. There Are Two New Imported Cases From Abroad,There is Also Good News![EB/OL]. (2020-05-07) [2020-05-08]. https://news.sina.com.cn/c/2020-05-07/doc- iirczymk0253210.shtml.
[20] Friedman D.Evolutionary Game in Economics[J]. Econometrica (S0012-9682) 1991, 59(3): 637-666.
[21] 搜狐网. 买了国外口罩的小伙伴！欧盟、美国、澳洲对于口罩质量认证标准都在这里[EB/OL]. (2020-02-01) [2020-07-23]. https://www.sohu.com/a/369974298_ 120538360.
Sohu. The European Union, the United States, Australia for Mask Quality Certification Standards are Here for Friends Who Bought a Foreign Mask![EB/OL]. (2020-02-01) [2020-07-23]. https://www.sohu.com/a/ 369974298_120538360.
[22] 陈洁, 莫甜甜. 中国口罩厂商出口调查: 一个单子就上千万个口罩, 原材料涨价15倍[EB/OL]. (2020-04-30) [2020-05-08]. https://new.qq.com/omn/20200322/20200 322A0EQBK00.html.
Chen Jie, Mo Tiantian. Chinese Mask Manufacturers Export Survey: a Single Order of 10 million Masks, Raw Materials 15 times the Price[EB/OL]. (2020-04-30) [2020-05-08]. https://new.qq.com/omn/20200322/20200 322A 0EQBK00.html.
[23] 中国台州网. 原材料难觅一只口罩成本涨了20多倍[EB/OL]. (2020-04-30) [2020-05-05]. http://www. taizhou.com.cn/myjj/2020-04/30/ content_6331192.htm.
China Taizhou Net. Raw Materials Are Scarce, and the Cost of a Mask Has Risen More Than 20-fold[EB/OL]. (2020-04-30) [2020-05-05]. http://www.taizhou.com.cn/ myjj/2020-04/30/content_6331192.htm.

进口国规制下医药产品出口安全监管演化仿真

Evolutionary Simulation of Medical Products Export Safety Supervision Considering Regulation of Importing Country

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	黄海涛, 刘勤明, 叶春明, 陈翔. 基于区块链技术的政府采购合同融资博弈分析[J]. 系统仿真学报, 2021, 33(8): 1947-1958.
[2]	李海滨, 王佳亮, 李海燕. 新冠后疫情时代复学风险评估的不确定性量化分析[J]. 系统仿真学报, 2021, 33(1): 13-23.
[3]	杨光明, 时岩钧. 基于演化博弈的长江三峡流域生态补偿机制研究[J]. 系统仿真学报, 2019, 31(10): 2058-2068.
[4]	魏德志, 陈福集, 林丽娜. 基于博弈论和SIRS的热点事件传播仿真研究[J]. 系统仿真学报, 2018, 30(6): 2050-2057.
[5]	彭本红, 谷晓芬, 鲁倩. 服务型制造项目治理中利益相关者演化博弈研究[J]. 系统仿真学报, 2017, 29(3): 595-608.
[6]	贺欢欢, 王兴伟, 黄敏. 认知无线电网络的一种演化博弈频谱共享机制[J]. 系统仿真学报, 2016, 28(3): 756-763.